Monte Rosa Therapeutics, Inc. (GLUE)
13.78
-0.52
(-3.67%)
USD |
NASDAQ |
Aug 24, 16:00
13.77
0.00 (0.00%)
After-Hours: 20:00
Monte Rosa Therapeutics EPS Diluted (Quarterly) : -0.4276 for June 30, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.4276 |
| March 31, 2026 | -0.4456 |
| December 31, 2025 | -0.7039 |
| September 30, 2025 | -0.3287 |
| June 30, 2025 | -0.1496 |
| March 31, 2025 | 0.5652 |
| December 31, 2024 | 0.2185 |
| September 30, 2024 | -0.2909 |
| June 30, 2024 | -0.4255 |
| March 31, 2024 | -0.5314 |
| December 31, 2023 | -0.5841 |
| September 30, 2023 | -0.7003 |
| June 30, 2023 | -0.7116 |
| Date | Value |
|---|---|
| March 31, 2023 | -0.6492 |
| December 31, 2022 | -0.6296 |
| September 30, 2022 | -0.5846 |
| June 30, 2022 | -0.5672 |
| March 31, 2022 | -0.5136 |
| December 31, 2021 | -0.5037 |
| September 30, 2021 | -0.4268 |
| June 30, 2021 | -0.4126 |
| March 31, 2021 | -0.279 |
| December 31, 2020 | -0.4517 |
| September 30, 2020 | -0.147 |
| June 30, 2020 | -0.1219 |
| March 31, 2020 | -0.0978 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Nurix Therapeutics, Inc. | -0.806 |
| Gilead Sciences, Inc. | -8.444 |
| Ironwood Pharmaceuticals, Inc. | 0.3068 |
| Capricor Therapeutics, Inc. | -0.7032 |
| Cue Biopharma, Inc. | -24.14 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -43.40M |
| Revenue (Quarterly) | 8.968M |
| Total Expenses (Quarterly) | 52.36M |
| Enterprise Value | 590.88M |
| Gross Profit Margin (Quarterly) | 78.69% |
| Profit Margin (Quarterly) | -483.9% |
| Earnings Yield | -13.84% |
| Normalized Earnings Yield | -13.83 |